Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Thorogood
J
J
Eurotransplant Foundation, University Hospital, Leiden, The Netherlands.
Schreuder
G M
GM
Persijn
G G
GG
van Rood
J J
JJ
D016572:Cyclosporine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000401:mortality / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology*; D006680:HLA Antigens / Q000276:immunology*; D015235:HLA-B Antigens / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D009426:Netherlands; D011183:Postoperative Complications / Q000276:immunology* / Q000401:mortality / Q000517:prevention & control; D011786:Quality Control; D015996:Survival Rate; D014019:Tissue Donors
D006680:HLA Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens; D016572:Cyclosporine